Literature DB >> 24520103

Preoperative Maximal Oxygen Uptake and Exercise-induced Changes in Pulse Oximetry Predict Early Postoperative Respiratory Complications in Lung Cancer Patients.

Y Fang1, G Ma2, N Lou2, W Liao2, D Wang2.   

Abstract

BACKGROUND: Postoperative respiratory complications often arise in lung cancer patients after lung resection, although these are often difficult to predict. We sought to identify reliable predictors of early-onset postoperative respiratory complications in lung cancer patients who had moderate-to-severe preoperative respiratory impairment.
METHODS: This was a prospective observational study that included 107 consecutive lung cancer patients with forced expiratory volume in 1 s <60% of predicted who were scheduled for thoracotomy and lung resection. Preoperative functional assessments included pulmonary function testing by spirometry, single breath diffusion capacity of lung for carbon monoxide, and cardiopulmonary exercise testing. Risk factors for early-onset postoperative respiratory complications that occurred within 30 days postoperatively were sought from among these pulmonary function testing and cardiopulmonary exercise testing results.
RESULTS: By multivariable logistic regression, peak oxygen uptake (V'O2max%; p < 0.001) and the transcutaneous pulse oxygen saturation difference during load exercise (ΔSPO2%; p < 0.001) were independent predictors of postoperative respiratory complications. A receiver operating characteristic curve had an area under the curve of 0.846 for the combination of V'O2max% and ΔSPO2%, while the area under the curve with V'O2max% only was 0.726. From this, the probability of postoperative respiratory complications was [Formula: see text]. Pcomplication ≥ 0.202 for postoperative respiratory complications had a sensitivity of 80.8% and a specificity of 81.5%.
CONCLUSIONS: For lung cancer patients with forced expiratory volume in 1 s <60% of predicted, in addition to common preoperative tests, V'O2max% and ΔSPO2% may be an aid for predicting early-onset postoperative respiratory complications. © The Finnish Surgical Society 2014.

Entities:  

Keywords:  Lung cancer surgery; lung pathology; lung physiology; pneumonectomy; pulmonary function

Year:  2014        PMID: 24520103     DOI: 10.1177/1457496913509235

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  5 in total

Review 1.  The Utility of Exercise Testing in Patients with Lung Cancer.

Authors:  Duc Ha; Peter J Mazzone; Andrew L Ries; Atul Malhotra; Mark Fuster
Journal:  J Thorac Oncol       Date:  2016-05-05       Impact factor: 15.609

2.  Effectiveness of Perioperative Cardiopulmonary Rehabilitation in Patients With Lung Cancer Undergoing Video-Assisted Thoracic Surgery.

Authors:  Wei-Hao Chao; Sheng-Hui Tuan; En-Kuei Tang; Yi-Ju Tsai; Jing-Hui Chung; Guan-Bo Chen; Ko-Long Lin
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 3.  Impact of preoperative exercise therapy on surgical outcomes in lung cancer patients with or without COPD: a systematic review and meta-analysis.

Authors:  Xiang Li; Shaolei Li; Shi Yan; Yaqi Wang; Xing Wang; Alan D L Sihoe; Yue Yang; Nan Wu
Journal:  Cancer Manag Res       Date:  2019-02-20       Impact factor: 3.989

4.  Exercise testing and postoperative complications after minimally invasive lung resection: A cohort study.

Authors:  Gabriel Chouinard; Pascalin Roy; Marie-Christine Blais; Alexandre Lippens; Éliane Pelletier; Emma Roy; Mathieu Marcoux; Paula A Ugalde; Justine Rheault; Marc-Antoine Pigeon; Frédéric Nicodème; Yves Lacasse; François Maltais
Journal:  Front Physiol       Date:  2022-09-23       Impact factor: 4.755

Review 5.  Preoperative Cardiopulmonary Exercise Test Associated with Postoperative Outcomes in Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analyses.

Authors:  Daniel Steffens; Hilmy Ismail; Linda Denehy; Paula R Beckenkamp; Michael Solomon; Cherry Koh; Jenna Bartyn; Neil Pillinger
Journal:  Ann Surg Oncol       Date:  2021-06-08       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.